News
USA-based biotech DoveTree Medicines has signed a far-reaching partnership with Chinese drug discovery company XtalPi (HKEX: 2228), in a deal worth up to $5.99 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback